Novel Regimen Boosts Survival for Recurrent Platinum-Resistant Ovarian Cancer

MedPage Today) — SAN JUAN, PUERTO RICO — A novel regimen for platinum-resistant ovarian cancer solidified its role as a treatment option with a significant improvement in overall survival (OS), according to a ROSELLA trial update.
Adding…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

This website is using cookies to improve the user-friendliness. You agree by using the website further.

Privacy policy
Skip to content